GR3015430T3 - 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide sulphate (2:1). - Google Patents

3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide sulphate (2:1).

Info

Publication number
GR3015430T3
GR3015430T3 GR940403944T GR940403944T GR3015430T3 GR 3015430 T3 GR3015430 T3 GR 3015430T3 GR 940403944 T GR940403944 T GR 940403944T GR 940403944 T GR940403944 T GR 940403944T GR 3015430 T3 GR3015430 T3 GR 3015430T3
Authority
GR
Greece
Prior art keywords
indole
dimethylamino
ethyl
methyl
methanesulphonamide sulphate
Prior art date
Application number
GR940403944T
Other languages
English (en)
Inventor
Joanne Craig
Derek Leslie Crookes
Stephen John Skittrall
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of GR3015430T3 publication Critical patent/GR3015430T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
GR940403944T 1990-12-12 1995-03-16 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide sulphate (2:1). GR3015430T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909026998A GB9026998D0 (en) 1990-12-12 1990-12-12 Medicaments

Publications (1)

Publication Number Publication Date
GR3015430T3 true GR3015430T3 (en) 1995-06-30

Family

ID=10686904

Family Applications (1)

Application Number Title Priority Date Filing Date
GR940403944T GR3015430T3 (en) 1990-12-12 1995-03-16 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide sulphate (2:1).

Country Status (36)

Country Link
US (2) US5554639A (el)
EP (1) EP0490689B1 (el)
JP (1) JP2994037B2 (el)
KR (1) KR100211479B1 (el)
CN (2) CN1030890C (el)
AP (1) AP230A (el)
AT (1) ATE119881T1 (el)
AU (1) AU650706B2 (el)
BE (1) BE1005085A3 (el)
CA (1) CA2098302C (el)
CH (1) CH684192A5 (el)
CY (1) CY2005A (el)
CZ (1) CZ281931B6 (el)
DE (1) DE69108200T2 (el)
DK (1) DK0490689T3 (el)
EG (1) EG20219A (el)
ES (1) ES2069836T3 (el)
FR (1) FR2670487B1 (el)
GB (2) GB9026998D0 (el)
GR (1) GR3015430T3 (el)
HK (1) HK82697A (el)
HU (1) HU211937A9 (el)
IE (1) IE62894B1 (el)
IL (1) IL100330A (el)
IS (1) IS1706B (el)
IT (1) IT1252868B (el)
MX (1) MX9102501A (el)
MY (1) MY109265A (el)
NL (1) NL9102071A (el)
NZ (1) NZ240942A (el)
PT (1) PT99757B (el)
RU (1) RU2108328C1 (el)
TW (2) TW205035B (el)
WO (1) WO1992010477A1 (el)
YU (1) YU48926B (el)
ZA (1) ZA919750B (el)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK279211B6 (sk) * 1992-06-05 1998-08-05 Merck Sharp & Dohme Limited Sulfátová soľ substituovaného triazolu, spôsob jej
FR2749846B1 (fr) * 1996-06-17 1998-09-11 Pf Medicament Sel de methanesulfonate d'une arylpiperazine derivee de tryptamine et ses solvates pour usage pharmaceutique
US8022095B2 (en) * 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US6106837A (en) * 1997-05-15 2000-08-22 Hirsch; Alan R. Method of treating headaches, and article of manufacture therefor
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
US6066092A (en) * 1997-11-06 2000-05-23 Cady; Roger K. Preemptive prophylaxis of migraine device and method
US6187790B1 (en) 1999-03-04 2001-02-13 Neal R. Cutler Use of cilostazol for treatment of sexual dysfunction
US6426084B1 (en) 2000-06-19 2002-07-30 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
US6132757A (en) 1998-05-01 2000-10-17 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
GB9926250D0 (en) * 1999-11-06 2000-01-12 Knoll Ag Chemical process
US20040115133A1 (en) * 2000-05-10 2004-06-17 Wermeling Daniel P. Intranasal opioid compositions
US6610271B2 (en) * 2000-05-10 2003-08-26 University Of Kentucky Research Foundation System and method for intranasal administration of lorazepam
US6458804B1 (en) * 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
US6562838B2 (en) 2001-01-26 2003-05-13 R. T. Alamo Ventures I, L.L.C. Treatment of cardiovascular disease with quinolinone enantiomers
US20040176359A1 (en) * 2001-02-20 2004-09-09 University Of Kentucky Research Foundation Intranasal Benzodiazepine compositions
US20030096748A1 (en) * 2001-06-04 2003-05-22 The Regents Of The University Of Michigan Methods and compositions for the treatment of diseases associated with signal transduction aberrations
US8329734B2 (en) * 2009-07-27 2012-12-11 Afgin Pharma Llc Topical therapy for migraine
DK1435945T3 (da) * 2001-06-05 2008-12-01 Ronald Aung-Din Topisk migræne terapi
US7041677B2 (en) * 2002-03-01 2006-05-09 R.T. Alamo Ventures I, Llc Use of monochloroflosequinan in the treatment of sexual dysfunction
US7208628B2 (en) * 2002-05-13 2007-04-24 Kansas State University Research Foundation Compositions and methods for the treatment of hepatitis C virus infection
US7074893B2 (en) * 2002-06-03 2006-07-11 Regents Of The University Of Michigan Methods and compositions for the treatment of diseases associated with signal transduction aberrations
US20040068000A1 (en) * 2002-10-02 2004-04-08 Mintong Guo Compression coated tablets
EP1575566B1 (en) * 2002-12-26 2012-02-22 Pozen, Inc. Multilayer dosage forms containing naproxen and triptans
US20080213363A1 (en) * 2003-01-23 2008-09-04 Singh Nikhilesh N Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa
WO2004076403A1 (en) * 2003-02-24 2004-09-10 Transform Pharmaceuticals, Inc. Sumatriptan crystalline forms, pharmaceutical compositions and methods
US20070065463A1 (en) * 2003-06-20 2007-03-22 Ronald Aung-Din Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions
US20050089558A1 (en) * 2003-10-28 2005-04-28 Alamo Pharmaceuticals, Llc Compositions and methods for the co-formulation and administration of tramadol and propoxyphene
WO2005119607A2 (en) * 2004-06-03 2005-12-15 Tyfone, Inc. System and method for securing financial transactions
WO2005123043A2 (en) * 2004-06-10 2005-12-29 Duramed Pharmaceuticals, Inc. Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
JP2008545650A (ja) 2005-05-20 2008-12-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ スルファミド誘導体の製造方法
WO2007070504A2 (en) * 2005-12-13 2007-06-21 Morton Grove Pharmaceuticals, Inc. Stable and palatable oral liquid sumatriptan compositions
AR058389A1 (es) 2005-12-19 2008-01-30 Janssen Pharmaceutica Nv Uso de derivados heterociclicos benzo-fusionados de sulfamida para el tratamiento de la obesidad
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8716231B2 (en) 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US20070191461A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of benzo-heteroaryl sulfamide derivatives for the treatment of migraine
WO2007137167A2 (en) 2006-05-19 2007-11-29 Janssen Pharmaceutica N.V. Co-therapy for the treatment of epilepsy
EP2124556B1 (en) 2006-10-09 2014-09-03 Charleston Laboratories, Inc. Pharmaceutical compositions
JP2010507585A (ja) * 2006-10-19 2010-03-11 オースペックス・ファーマシューティカルズ・インコーポレイテッド 置換インドール
US20080275030A1 (en) 2007-01-19 2008-11-06 Sveinbjorn Gizurarson Methods and Compositions for the Delivery of a Therapeutic Agent
GB2448183A (en) * 2007-04-05 2008-10-08 Optinose As Nasal powder delivery device
CA2905541C (en) 2008-01-09 2020-02-11 Charleston Laboratories, Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
US20090252791A1 (en) * 2008-04-02 2009-10-08 Venkata Nookaraju Sreedharala Pharmaceutical compositions comprising a triptan and a nonsteroidal anti-inflammatory drug
BRPI0912038A2 (pt) 2008-05-27 2017-06-20 Biota Scient Management Pty Ltd composto, mistura, composição farmacêutica, uso do composto, e, métodos para tratar e evitar uma infecção por picornavírus, e para formar o composto
WO2009152551A1 (en) * 2008-06-20 2009-12-23 Alphapharm Pty Ltd Pharmaceutical formulation
AU2009271362B2 (en) 2008-06-23 2014-03-13 Janssen Pharmaceutica Nv Crystalline form of (2s)-(-)-N-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide
US8592424B2 (en) * 2008-06-30 2013-11-26 Afgin Pharma Llc Topical regional neuro-affective therapy
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
EP3311667A1 (en) 2009-07-08 2018-04-25 Charleston Laboratories, Inc. Pharmaceutical compositions
US11337962B2 (en) 2009-09-25 2022-05-24 Upsher-Smith Laboratories, Llc Formulations comprising triptan compounds
KR101646079B1 (ko) 2009-09-25 2016-08-12 닥터 레디스 레보러터리즈 리미티드 트립탄 화합물을 포함하는 제제
US10383816B2 (en) 2015-03-02 2019-08-20 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoid combination products
JP2018507262A (ja) 2015-03-02 2018-03-15 アフギン ファーマ, エルエルシーAfgin Pharma, Llc カンナビノイドを用いた、局所局部的神経作用療法
US10494405B2 (en) 2015-05-15 2019-12-03 The Regents Of The University Of Michigan Methods and compositions for the treatment of arthritis
CA3055170A1 (en) 2016-03-04 2017-09-08 Charleston Laboratories, Inc. Pharmaceutical compositions
US20180049994A1 (en) 2016-08-16 2018-02-22 Afgin Pharma, Llc Topical regional neuro-affective therapy with caryophyllene
JP2021502361A (ja) 2017-11-07 2021-01-28 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 共有エピトープ−カルレティキュリン相互作用の小分子阻害薬及び使用方法
WO2020049523A1 (en) 2018-09-07 2020-03-12 Upsher-Smith Laboratories, Llc Methods of treating migraine
US11364225B2 (en) * 2019-08-21 2022-06-21 Bn Intellectual Properties, Inc. Pharmaceutical formulation for treating symptoms of migraine and cluster headaches, and method of using the same
US20230108049A1 (en) * 2020-02-27 2023-04-06 Biohaven Pharmaceutical Holding Company Ltd. Oral fast-dispersing dosage form of rimegepant

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
GB8615599D0 (en) * 1986-06-26 1986-07-30 Glaxo Group Ltd Chemical compounds
GB8928208D0 (en) * 1989-12-13 1990-02-14 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
ITRM910922A1 (it) 1993-06-11
US5554639A (en) 1996-09-10
IE62894B1 (en) 1995-03-08
TW300886B (el) 1997-03-21
ZA919750B (en) 1992-10-28
JPH06503560A (ja) 1994-04-21
AP230A (en) 1993-01-27
CN1128259A (zh) 1996-08-07
ES2069836T3 (es) 1995-05-16
GB9126297D0 (en) 1992-02-12
JP2994037B2 (ja) 1999-12-27
KR100211479B1 (ko) 1999-08-02
BE1005085A3 (fr) 1993-04-13
TW205035B (el) 1993-05-01
FR2670487B1 (fr) 1993-08-20
PT99757B (pt) 1999-05-31
IS3790A7 (is) 1992-06-13
IE914317A1 (en) 1992-06-17
CZ114093A3 (en) 1994-02-16
MX9102501A (es) 1992-09-01
PT99757A (pt) 1992-12-31
US5705520A (en) 1998-01-06
EP0490689B1 (en) 1995-03-15
DK0490689T3 (da) 1995-05-22
YU191491A (sh) 1994-04-05
CN1063099A (zh) 1992-07-29
HU211937A9 (en) 1996-01-29
RU2108328C1 (ru) 1998-04-10
GB9026998D0 (en) 1991-01-30
ATE119881T1 (de) 1995-04-15
CY2005A (en) 1997-12-05
CA2098302A1 (en) 1992-06-13
GB2251614A (en) 1992-07-15
IL100330A (en) 1996-06-18
IS1706B (is) 1998-12-10
YU48926B (sh) 2002-12-10
IT1252868B (it) 1995-06-28
FR2670487A1 (fr) 1992-06-19
MY109265A (en) 1996-12-31
IL100330A0 (en) 1992-09-06
CH684192A5 (fr) 1994-07-29
CA2098302C (en) 2001-10-16
EG20219A (en) 1997-11-30
HK82697A (en) 1997-06-27
NZ240942A (en) 1994-03-25
AU650706B2 (en) 1994-06-30
WO1992010477A1 (en) 1992-06-25
ITRM910922A0 (it) 1991-12-11
CZ281931B6 (cs) 1997-04-16
DE69108200D1 (de) 1995-04-20
NL9102071A (nl) 1992-07-01
AU9072091A (en) 1992-07-08
DE69108200T2 (de) 1995-07-20
GB2251614B (en) 1994-12-14
EP0490689A1 (en) 1992-06-17
CN1050831C (zh) 2000-03-29
AP9100339A0 (en) 1992-01-31
CN1030890C (zh) 1996-02-07

Similar Documents

Publication Publication Date Title
GR3015430T3 (en) 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide sulphate (2:1).
HU9302460D0 (en) 5/20/4-(1,2-benzisothiazole-3-yl)-1-pierazinyl/ethyl/-6-chlorine-1,3-dihydro-2h-indole-2-one-hydrogen-chloride-mononhydrate
HU9200302D0 (en) 1,3-oxatiolane-nucleotide analogues
HU9203505D0 (en) 1,4-diamino-2,3-dihydroxi-butane compounds
AR244082A1 (es) Composiciones de champu
EP0569493A4 (en) Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines
ZA916015B (en) 2-(9-fluorenonyl)-carbapenem
GR3030863T3 (en) 2',5'-oligoadenylate-2',3'-cyclophosphates
GB2260135B (en) Substituted 2,6-diaminotoluenes
EP0481950A3 (en) 1,4-dideoxy-4-fluoronojirimycin
HU908313D0 (en) New 15-nitro-2betha, 3betha-dihydro- and 15-nitro-2betha, 3 betha,6,7-tetrahydro-tabersonine derivatives
ZA933848B (en) Pyridyl-1,2,5-oxadiazolecarboxamide-2-oxides
HU913818D0 (en) New 2,6-alkoxy-phenyl-alkyl-ketones and herbicide preparatives containing said compounds
OA09328A (en) "Heterocyclic compounds".
GB9026078D0 (en) Printing
EP0437416A3 (en) Compositions containing a 2,2',2"-nitrilotriethanol-cyclometallate
DE59507706D1 (en) 2-(2,4,6-trimethylphenyl)-cyclopentan-1,3-dion-derivate
IL93686A0 (en) 4,4'-diamino-3-methyl-diphenylether-bis-maleimide
IE900875L (en) 1,4-dihydro-4-oxo-naphthyridine-3-carboxylate
IE900472L (en) 2,3,23-trihydroxy-urs-12-ene
IE902043L (en) 2,5-diaryltetrahydrofurans
IE900892L (en) Quinolin-2-yl-methoxyphenyl-n,n'-sulphonylureas
GB9123106D0 (en) The'd'machine
CS32591A3 (en) 1,2,3,4-di-0-isopropyliden-6-0-epoxypropyl-alpha-d-galactopyranose
HU906221D0 (en) "tuti-toto"